Surgery – Blood drawn and replaced or treated and returned to body – Constituent removed from blood and remainder returned to body
Reexamination Certificate
2005-02-02
2008-03-04
Bianco, Patricia (Department: 3772)
Surgery
Blood drawn and replaced or treated and returned to body
Constituent removed from blood and remainder returned to body
C604S004010, C435S001100, C435S284100, C210S645000
Reexamination Certificate
active
07338461
ABSTRACT:
Methods and devices are provided that improve the function of organ support devices, and also provided are improved methods of treating conditions associated with hemodynamic instability.
REFERENCES:
patent: 4675002 (1987-06-01), Viles et al.
patent: 4885087 (1989-12-01), Kopf
patent: 5290684 (1994-03-01), Kelly
patent: 5368555 (1994-11-01), Sussman et al.
patent: 5643794 (1997-07-01), Liu et al.
patent: 5976870 (1999-11-01), Park
patent: 6294380 (2001-09-01), Qiang et al.
patent: 6582955 (2003-06-01), Martinez et al.
patent: 6913588 (2005-07-01), Weitzel et al.
patent: 2003/0054544 (2003-03-01), Gruenberg
patent: 2003/0228685 (2003-12-01), Nyberg
Bolasco et al., “Convection versus diffusion in dialysis: an Italian prospective multicentre study,” Nephrol. Dial. Transplant. 18 [Suppl 7]:vii50-vii54 (2003).
Borra et al., “Mixed predilution and postdilution online hemodiafiltration compared with the traditional infusion modes,” Int. J. Artif. Organs. 25:939-949 (2002).
Pedrini et al., “Advanced technology for extracorporeal liver support system devices,” Kid. Int. 58(5):2155-65 (2000).
“Deaths and Hospitalizations from Chronic Liver Disease and Cirrhosis—United States, 1980-1989,” MMWR 41(52):969-973, Jan. 8, 1993 http://www.cdc.gov/mmwr/preview/mmwrhtm1/00018761.htm.
Awad, S. et al., “Results of a Phase I Trial Evaluating a Liver Support Device Utilizing Albumin Dialysis,” Surgery 120(2):354-362, Aug. 2001.
De Vriese, A. et al., “Cytokine Removal during Continuous Hemofiltration in Septic Patients,” J. Am. Soc. Nephrol, 10:846-853, 1999.
Detry, O. et al., “Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure,” Am. Surg., 65(10):934-8, Oct. 1999.
Ellis, A. et al., “Pilot-Controlled Trial of the Extracorporeal Liver Assist Device in Acute Liver Failure,” Hepatology, 24(6):1446-1451, 1996.
Ferenci, P. “Pathogenesis of Hepatic Encephalopathy,” UpToDate, 2003 http://www.utdol.com/application/topic/print.asp?file=cirrhosi/7310&type=A&selectedTi...
Forsythe, S. and Schmidt, G., “Sodium Bicarbonate for the Treatment of Lactic Acidosis,” CHEST, 117(1):260-267, Jan. 2000.
Kellum, J. et al., “Diffusive vs. convective therapy: Effects on Mediators of Inflammation in Patients with Severe Systemic Inflammatory Response Syndrome,” Crit. Care Med., 26(12):1995-2000, Dec. 1998.
Kim, W. et al., “Burden of Liver Disease in the United States: Summary of a Workshop,” Hepatology 36(1):227-242, Jul. 2002.
Kjaergard, L. et al., “Artificial and Bioartificial Support Systems for Acute and Acute-on-Chronic Liver Failure,” JAMA, 239(2):217-222, Jan. 8, 2003.
Levraut, J. et al., “Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients,” Crit. Care Med., 25(1):58-62, Jan. 1997.
Maxvold, N. et al., “Amino acid loss and nitrogen balance in critically ill children with acute renal failure: A prospective comparison between classic hemofiltration and hemofiltration with dialysis,” Crit. Care Med., 28(4):1161-1165, Apr. 2000.
Millis, J. et al., “Initial Experience with the Modified Extracorporeal Liver-Assist Device for Patients with Fulminant Hepatic Failure: System Modifications and Clinical Impact,” Transplantation, 74(12):1735-1746, Dec. 27, 2002.
Mitzner, S. et al., “Extracoporeal Detoxification Using the Molecular Adsorbent Recirculating System for Critically Ill Patients with Liver Failure,” J. Am. Soc. Nephrol., 12:S75-S82, 2001.
Patzer, J. et al., “Novel Bioartifical Liver Support System: Preclinical Evaluation,” Annals New York Academy of Sciences, p. 340-352., 1999.
Patzer, J. et al., “Preclinical Evaluation of the Excorp Medical, Inc, Bioartificial Liver Support System,” J. Am. Coll. Surg., 195(3):299-310, Sep. 2002.
Pazzi, P. et al., “Serum bile acids in patients with liver failure supported with a bioartificial liver,” Alimentary Pharmacology & Therapeutics, 16(8):1547, Aug. 2002.
Sauer, I. et al., “Development of a Hybrid Liver Support System,” Annals New York Academy of Sciences, p. 308-319, 2001.
Stevens, C. “Liver Support Systems,” UpToDate, 2003, http://www.utdol.com/application/topic/print.asp?file=hep—dis/I6014&type=A&selectedTi..
Strain, A. and Neuberger, J., “A Bioartificial Liver—State of the Art,” Science 295:1005-1009, Feb. 8, 2002.
Linde Peter G.
Williams Winfred W.
Bianco Patricia
The General Hospital Corporation
LandOfFree
Modified organ support devices does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified organ support devices, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified organ support devices will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3966039